Indeed, the observations that glioma cells can have variable degrees of Tpmt protein activity and that low protein activity can cause cells to be more sensitive to TG poses the question of whether thiopurines may potentially have a therapeutic role in low Tpmt expressing glial tumors. This evidence concerns the gene TPMT and glioma.